IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v39y1997i3p181-194.html
   My bibliography  Save this article

Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy

Author

Listed:
  • Townsend, Joy
  • Buxton, Martin

Abstract

No abstract is available for this item.

Suggested Citation

  • Townsend, Joy & Buxton, Martin, 1997. "Cost effectiveness scenario analysis for a proposed trial of hormone replacement therapy," Health Policy, Elsevier, vol. 39(3), pages 181-194, March.
    • Handle: RePEc:eee:hepoli:v:39:y:1997:i:3:p:181-194
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(96)00870-6
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Maria Goddard, 1990. "The cost-effectiveness of hormone replacement therapy: a review," Working Papers 073chedp, Centre for Health Economics, University of York.
    2. Michael Parsonage & Henry Neuburger, 1992. "Discounting and health benefits," Health Economics, John Wiley & Sons, Ltd., vol. 1(1), pages 71-76, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Karnon, Jonathan, 2002. "Planning the efficient allocation of research funds: an adapted application of a non-parametric Bayesian value of information analysis," Health Policy, Elsevier, vol. 61(3), pages 329-347, September.
    2. Felli, James C. & Anderson, Wesley H. & Kremidas, James P. & Ruberg, Stephen J., 2007. "A semi-Markov model for patient progression through clinical trials," European Journal of Operational Research, Elsevier, vol. 176(1), pages 542-549, January.
    3. Rachael L. Fleurence, 2007. "Setting priorities for research: a practical application of ‘payback’ and expected value of information," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1345-1357, December.
    4. Fleurence, Rachael L. & Torgerson, David J., 2004. "Setting priorities for research," Health Policy, Elsevier, vol. 69(1), pages 1-10, July.
    5. Lazaros Andronis & Pelham M. Barton, 2016. "Adjusting Estimates of the Expected Value of Information for Implementation," Medical Decision Making, , vol. 36(3), pages 296-307, April.
    6. Lazaros Andronis & Lucinda J. Billingham & Stirling Bryan & Nicholas D. James & Pelham M. Barton, 2016. "A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative Research," Medical Decision Making, , vol. 36(3), pages 321-334, April.
    7. Rachael L. Fleurence, 2007. "Setting priorities for research: a practical application of 'payback' and expected value of information," Health Economics, John Wiley & Sons, Ltd., vol. 16(12), pages 1345-1357.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Mike McKenna & Alan Maynard & Ken Wright, 1992. "Is rehabilitation cost effective?," Working Papers 101chedp, Centre for Health Economics, University of York.
    2. John Hutton, 2012. "‘Health Economics’ and the evolution of economic evaluation of health technologies," Health Economics, John Wiley & Sons, Ltd., vol. 21(1), pages 13-18, January.
    3. Paul Dolan & Claire Gudex, 1995. "Time preference, duration and health state valuations," Health Economics, John Wiley & Sons, Ltd., vol. 4(4), pages 289-299, July.
    4. Alireza Mahboub-Ahari & Abolghasem Pourreza & Ali Akbari Sari & Trevor A Sheldon & Maryam Moeeni, 2019. "Private and social time preference for health outcomes: A general population survey in Iran," PLOS ONE, Public Library of Science, vol. 14(2), pages 1-13, February.
    5. Nancy Thiry & Philippe Beutels & Pierre Damme & Eddy Doorslaer, 2003. "Economic Evaluations of Varicella Vaccination Programmes," PharmacoEconomics, Springer, vol. 21(1), pages 13-38, January.
    6. Davies, Ruth & Roderick, Paul & Raftery, James, 2003. "The evaluation of disease prevention and treatment using simulation models," European Journal of Operational Research, Elsevier, vol. 150(1), pages 53-66, October.
    7. David K. Whynes & Aileen R. Neilson & Andrew R. Walker & Jack D. Hardcastle, 1998. "Faecal occult blood screening for colorectal cancer: is it cost‐effective?," Health Economics, John Wiley & Sons, Ltd., vol. 7(1), pages 21-29, February.
    8. Angelina Lazaro & Ramon Barberan & Encarnacion Rubio, 2002. "The economic evaluation of health programmes: why discount health consequences more than monetary consequences?," Applied Economics, Taylor & Francis Journals, vol. 34(3), pages 339-350.
    9. Robberstad, Bjarne, 2005. "Estimation of private and social time preferences for health in northern Tanzania," Social Science & Medicine, Elsevier, vol. 61(7), pages 1597-1607, October.
    10. Andrew Briggs, 1995. "Handling Uncertainty in the Results of Economic Evaluation," Briefing 000410, Office of Health Economics.
    11. Ben A. Van Hout, 1998. "Discounting costs and effects: a reconsideration," Health Economics, John Wiley & Sons, Ltd., vol. 7(7), pages 581-594, November.
    12. Erik Nord, 2011. "Discounting future health benefits: the poverty of consistency arguments," Health Economics, John Wiley & Sons, Ltd., vol. 20(1), pages 16-26, January.
    13. Louise Young, 2002. "Determining the Discount Rate for Government Projects," Treasury Working Paper Series 02/21, New Zealand Treasury.
    14. Jan Abel Olsen, 1993. "Time preferences for health gains: An empirical investigation," Health Economics, John Wiley & Sons, Ltd., vol. 2(3), pages 257-265, October.
    15. Niek Stadhouders & Xander Koolman & Christel van Dijk & Patrick Jeurissen & Eddy Adang, 2019. "The marginal benefits of healthcare spending in the Netherlands: Estimating cost‐effectiveness thresholds using a translog production function," Health Economics, John Wiley & Sons, Ltd., vol. 28(11), pages 1331-1344, November.
    16. Weinert, Jan-Hendrik & Gründl, Helmut, 2016. "The modern tontine: An innovative instrument for longevity risk management in an aging society," ICIR Working Paper Series 22/16, Goethe University Frankfurt, International Center for Insurance Regulation (ICIR).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:39:y:1997:i:3:p:181-194. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.